Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: Clin Cancer Res. 2019 Apr 16;25(14):4231–4237. doi: 10.1158/1078-0432.CCR-18-3886

Figure 2. Enriched gene sets (FDR<0.05) in hallmark pathways curated in the MSigDB (Broad Institute).

Figure 2

Graph indicates the number of genes in the set that were significantly differentially expressed between responders and resistant patients at baseline (pre-treatment).